Biopharmaceutical giant AstraZeneca announced today it plans to create a research and development center in Gaithersburg, adding 300 jobs at MedImmune’s current location.
MedImmune’s director of corporate public relations, Tracy Rossin, said no new buildings are planned at this point. Biotech company MedImmune, which is owned by AstraZeneca, currently houses AstraZeneca’s biologics programs, geared toward the creation of vaccines and medications.
{iframe}http://www.gazette.net/article/20130318/NEWS/130319311/1022/astrazeneca-to-add-300-jobs-at-gaithersburg-x2019-s-medimmune-campus&template=gazette{/iframe}